
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11114900
[patent_doc_number] => 20160311873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'SEMAPHORIN 3C VARIANTS, COMPOSITIONS COMPRISING SAID VARIANTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/917152
[patent_app_country] => US
[patent_app_date] => 2014-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24594
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917152
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917152 | Semaphorin 3C variants, compositions comprising said variants and methods of use thereof | Sep 6, 2014 | Issued |
Array
(
[id] => 9902441
[patent_doc_number] => 20150057641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'NON-PATHOGENIC BIOFILMS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/466325
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12594
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/466325 | Non-pathogenic biofilms and uses thereof | Aug 21, 2014 | Issued |
Array
(
[id] => 11767923
[patent_doc_number] => 09376499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'PAR-1 activation by metalloproteinase-1 (MMP-1)'
[patent_app_type] => utility
[patent_app_number] => 14/460353
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 23
[patent_no_of_words] => 33746
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14460353
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/460353 | PAR-1 activation by metalloproteinase-1 (MMP-1) | Aug 13, 2014 | Issued |
Array
(
[id] => 10989260
[patent_doc_number] => 20160186204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/912356
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 112343
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912356 | Insecticidal proteins and methods for their use | Aug 13, 2014 | Issued |
Array
(
[id] => 10684177
[patent_doc_number] => 20160030322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'Applications of Surfactin in Cosmetic Products'
[patent_app_type] => utility
[patent_app_number] => 14/448401
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9905
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448401
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/448401 | Method for anti-aging treatment by surfactin in cosmetics via enhancing sirtuin | Jul 30, 2014 | Issued |
Array
(
[id] => 11190021
[patent_doc_number] => 09420816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'High protein liquid enteral nutritional composition'
[patent_app_type] => utility
[patent_app_number] => 14/337085
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 11886
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14337085
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/337085 | High protein liquid enteral nutritional composition | Jul 20, 2014 | Issued |
Array
(
[id] => 10822035
[patent_doc_number] => 20160168199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 14/905754
[patent_app_country] => US
[patent_app_date] => 2014-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30027
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/905754 | TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE | Jul 15, 2014 | Abandoned |
Array
(
[id] => 13675169
[patent_doc_number] => 20160376318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE
[patent_app_type] => utility
[patent_app_number] => 14/904674
[patent_app_country] => US
[patent_app_date] => 2014-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/904674 | POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE | Jul 15, 2014 | Abandoned |
Array
(
[id] => 10919699
[patent_doc_number] => 20140322718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'COMPETENCE STIMULATING PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/327422
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10071
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327422
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/327422 | Competence stimulating peptide | Jul 8, 2014 | Issued |
Array
(
[id] => 9805753
[patent_doc_number] => 20150017699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'Internally functionalized graphene substrates'
[patent_app_type] => utility
[patent_app_number] => 14/120928
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 8902
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14120928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/120928 | Internally functionalized graphene substrates | Jul 8, 2014 | Issued |
Array
(
[id] => 9838500
[patent_doc_number] => 20150030581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'LPL VARIANT THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 14/324151
[patent_app_country] => US
[patent_app_date] => 2014-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12269
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324151 | LPL variant therapeutics | Jul 3, 2014 | Issued |
Array
(
[id] => 9901100
[patent_doc_number] => 20150056301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION USES AND TREATMENTS FOR CANCER PATIENT SUBPOPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/313264
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32884
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14313264
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/313264 | Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations | Jun 23, 2014 | Issued |
Array
(
[id] => 15816503
[patent_doc_number] => 10633417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Conotoxin peptides, pharmaceutical compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/894967
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 16570
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894967 | Conotoxin peptides, pharmaceutical compositions and uses thereof | May 29, 2014 | Issued |
Array
(
[id] => 9792723
[patent_doc_number] => 20150004667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Functionalized graphene substrates'
[patent_app_type] => utility
[patent_app_number] => 14/120485
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8622
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14120485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/120485 | Functionalized graphene substrates | May 22, 2014 | Issued |
Array
(
[id] => 10784159
[patent_doc_number] => 20160130315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'TUMOR TISSUE-PENETRATING PEPTIDE SPECIFIC TO NEUROPILIN AND FUSION PROTEIN HAVING SAME PEPTIDE FUSED THEREIN'
[patent_app_type] => utility
[patent_app_number] => 14/893317
[patent_app_country] => US
[patent_app_date] => 2014-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20057
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893317 | Tumor tissue-penetrating peptide specific to neuropilin and fusion protein having same peptide fused therein | May 21, 2014 | Issued |
Array
(
[id] => 10721160
[patent_doc_number] => 20160067308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'USE OF HUMAN SMALL LEUCINE ZIPPER PROTEIN IN OSTEOGENESIS PROCEDURE'
[patent_app_type] => utility
[patent_app_number] => 14/888340
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9808
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888340
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/888340 | Use of human small leucine zipper protein in osteogenesis procedure | Apr 29, 2014 | Issued |
Array
(
[id] => 13222809
[patent_doc_number] => 10125169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Protransduzin B, a gene transfer enhancer
[patent_app_type] => utility
[patent_app_number] => 14/787160
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1967
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787160 | Protransduzin B, a gene transfer enhancer | Apr 29, 2014 | Issued |
Array
(
[id] => 10799146
[patent_doc_number] => 20160145303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/786160
[patent_app_country] => US
[patent_app_date] => 2014-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5816
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786160 | Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof | Apr 24, 2014 | Abandoned |
Array
(
[id] => 10774782
[patent_doc_number] => 20160120938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY'
[patent_app_type] => utility
[patent_app_number] => 14/786630
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9193
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786630
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786630 | P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY | Apr 22, 2014 | Abandoned |
Array
(
[id] => 10714146
[patent_doc_number] => 20160060293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'COMPOSITIONS AND METHOD FOR TREATING THROMBOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/784684
[patent_app_country] => US
[patent_app_date] => 2014-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11938
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14784684
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/784684 | Compositions and method for treating thrombosis | Apr 17, 2014 | Issued |